Kura spins diabetes work into a Lilly-backed biotech startup

Summary

Kura has spun out diabetes and cardiometabolic work into Caspian Therapeutics, a biotech startup backed by Eli Lilly, to develop menin inhibitors which have shown efficacy in leukemia for new indications.